Evidence map›Paper›PMID 42886691›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Omega-3 fatty acids reprogram tumor-associated macrophage cytokine signaling and suppress pancreatic cancer growth.

Stephen Sakuma, Steven Zhao, Andrew Hildreth, Gloria Liu, Valisha Shah, Ming Sun, Shirong Tan, Emily Jacobs, Michael A LaPorta, Jesse Furguiele and 12 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Omega-3 fatty acids reprogram tumor-associated macrophage cytokine signaling and suppress pancreatic cancer growth.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Stephen Sakuma *NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
Steven Zhao *NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
Andrew HildrethNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
Gloria LiuNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
Valisha ShahNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
Ming SunNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
Shirong TanNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
Emily JacobsNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
Michael A LaPortaNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
Jesse FurguieleNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
Natalia Avina-OchoaNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
Anna-Maria GlobigNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
Victoria TrippleNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.
ImmgenT Consortium
Geraldine MaierRegulatory Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037.
Satchidananda PandaRegulatory Biology Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037.ORCID 0000-0002-7855-0091
Michelle L ReyzerDepartment of Biochemistry, Mass Spectrometry Research Center, Vanderbilt University, Nashville, TN 37232.
Jing X KangDepartment of Medicine, Laboratory for Lipid Medicine and Technology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02129.
David W L MaDepartment of Human Health and Nutritional Sciences, University of Guelph, Guelph, ON N1G 2W1, Canada.ORCID 0000-0002-1165-5972
Matthew RodehefferDepartment of Comparative Medicine, Yale School of Medicine, New Haven, CT 06520.
Saame Raza ShaikhDepartment of Nutrition, Gillings School of Global Public Health and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.
Susan M KaechNOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA 92037.ORCID 0000-0003-1674-1420

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Ye Zheng · 1985 to 2026
$82.8M
Salk Institute Cancer Training GrantT32CA009370 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Diana Clare Hargreaves, Jan Karlseder · 1986 to 2026
$8.6M
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunityR01CA240909 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI KAECH, SUSAN M · 2020 to 2024
$3.0M
Understanding omega-3 and 6 fatty acid dependent regulation of inflammatory signals in pancreatic cancerU01CA293476 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Susan M Kaech · 2025 to 2026
$1.5M
Metabolic rewiring regulates cancer growth and tumor-associated immune responsesK00CA222741 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI ZHAO, STEVEN · 2020 to 2023
$348k
The role of the CCR4-NOT complex in the regulation of Nuclear Pore Complex assemblyK00CA274682 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Stephen Sakuma · 2024 to 2026
$272k
HHS | NIH | National Cancer Institute (NCI) K00 CA222741HHS | NIH | National Cancer Institute (NCI) K00 CA274682HHS | NIH | National Cancer Institute (NCI) P30 CA014195HHS | NIH | National Cancer Institute (NCI) R01 CA240909HHS | NIH | National Cancer Institute (NCI) T32 CA009370HHS | NIH | National Cancer Institute (NCI) U01 CA293476
6 · The paper itself

Abstract

Dietary polyunsaturated fatty acids (PUFAs) shape inflammatory signaling within the pancreatic tumor microenvironment (TME), but the cellular mechanisms underlying their effects on tumor progression remain unclear. Using orthotopic models of pancreatic ductal adenocarcinoma (PDAC), we show that omega-3 (n-3) and omega-6 (n-6) PUFAs are differentially incorporated into tumor lipid pools, generating spatially heterogeneous lipid microenvironments. While an n-6-enriched diet accelerated PDAC growth, an n-3-enriched diet suppressed tumor growth in a T cell-independent manner. Examining inflammatory effects in PDAC tumors, the n-3 PUFA-enriched diet reduced pro-inflammatory cytokines, including IL-6 family members, and single-cell and spatial analyses identified tumor-associated macrophages (TAMs) as the primary diet-responsive population. Indeed, selective conversion of n-6 to n-3 fatty acids within myeloid cells using an inducible

Indexed as

Carcinoma, Pancreatic DuctalCytokinesFatty Acids, Omega-3Pancreatic NeoplasmsTumor-Associated MacrophagesAnimalsCaenorhabditis elegans ProteinsCell Line, TumorFatty Acid DesaturasesFatty Acids, Omega-6HumansMacrophagesMiceSignal TransductionTumor MicroenvironmentCaenorhabditis elegans ProteinsCytokinesfat-1 protein, C elegansFatty Acid DesaturasesFatty Acids, Omega-3Fatty Acids, Omega-6cytokine signalingomega-3 fatty acidsPDACtumor-associated macrophagestumor microenvironment

Identifiers

PMID42886691
PMCPMC13684287

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.